211 related articles for article (PubMed ID: 26835700)
1. Hyperuricaemia: contributions of urate transporter ABCG2 and the fractional renal clearance of urate.
Kannangara DR; Phipps-Green AJ; Dalbeth N; Stamp LK; Williams KM; Graham GG; Day RO; Merriman TR
Ann Rheum Dis; 2016 Jul; 75(7):1363-6. PubMed ID: 26835700
[TBL] [Abstract][Full Text] [Related]
2. ABCG2 dysfunction increases the risk of renal overload hyperuricemia.
Matsuo H; Takada T; Nakayama A; Shimizu T; Sakiyama M; Shimizu S; Chiba T; Nakashima H; Nakamura T; Takada Y; Sakurai Y; Hosoya T; Shinomiya N; Ichida K
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):266-74. PubMed ID: 24940678
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout.
Wrigley R; Phipps-Green AJ; Topless RK; Major TJ; Cadzow M; Riches P; Tausche AK; Janssen M; Joosten LAB; Jansen TL; So A; Harré Hindmarsh J; Stamp LK; Dalbeth N; Merriman TR
Arthritis Res Ther; 2020 Mar; 22(1):45. PubMed ID: 32164793
[TBL] [Abstract][Full Text] [Related]
4. The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion.
Hoque KM; Dixon EE; Lewis RM; Allan J; Gamble GD; Phipps-Green AJ; Halperin Kuhns VL; Horne AM; Stamp LK; Merriman TR; Dalbeth N; Woodward OM
Nat Commun; 2020 Jun; 11(1):2767. PubMed ID: 32488095
[TBL] [Abstract][Full Text] [Related]
5. [Recent progress and prospects for research on urate efflux transporter ABCG2].
Ichida K
Nihon Rinsho; 2014 Apr; 72(4):757-65. PubMed ID: 24796111
[TBL] [Abstract][Full Text] [Related]
6. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
Torres RJ; Puig JG
Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
[TBL] [Abstract][Full Text] [Related]
7. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
[TBL] [Abstract][Full Text] [Related]
8. ABCG2 as a therapeutic target candidate for gout.
Fujita K; Ichida K
Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
[TBL] [Abstract][Full Text] [Related]
9. Decreased extra-renal urate excretion is a common cause of hyperuricemia.
Ichida K; Matsuo H; Takada T; Nakayama A; Murakami K; Shimizu T; Yamanashi Y; Kasuga H; Nakashima H; Nakamura T; Takada Y; Kawamura Y; Inoue H; Okada C; Utsumi Y; Ikebuchi Y; Ito K; Nakamura M; Shinohara Y; Hosoyamada M; Sakurai Y; Shinomiya N; Hosoya T; Suzuki H
Nat Commun; 2012 Apr; 3():764. PubMed ID: 22473008
[TBL] [Abstract][Full Text] [Related]
10. ABCG2 is a high-capacity urate transporter and its genetic impairment increases serum uric acid levels in humans.
Nakayama A; Matsuo H; Takada T; Ichida K; Nakamura T; Ikebuchi Y; Ito K; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1091-7. PubMed ID: 22132962
[TBL] [Abstract][Full Text] [Related]
11. Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge.
Dalbeth N; House ME; Gamble GD; Pool B; Horne A; Purvis L; Stewart A; Merriman M; Cadzow M; Phipps-Green A; Merriman TR
Arthritis Res Ther; 2014 Jan; 16(1):R34. PubMed ID: 24476385
[TBL] [Abstract][Full Text] [Related]
12. ABCG2/BCRP dysfunction as a major cause of gout.
Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Suzuki H; Hosoya T; Shinomiya N
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1117-28. PubMed ID: 22132966
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of ABCG2, a urate exporter, by parathyroid hormone enhances urate accumulation in secondary hyperparathyroidism.
Sugimoto R; Watanabe H; Ikegami K; Enoki Y; Imafuku T; Sakaguchi Y; Murata M; Nishida K; Miyamura S; Ishima Y; Tanaka M; Matsushita K; Komaba H; Fukagawa M; Otagiri M; Maruyama T
Kidney Int; 2017 Mar; 91(3):658-670. PubMed ID: 27988213
[TBL] [Abstract][Full Text] [Related]
14. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.
Woodward OM; Köttgen A; Coresh J; Boerwinkle E; Guggino WB; Köttgen M
Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10338-42. PubMed ID: 19506252
[TBL] [Abstract][Full Text] [Related]
15. ABCG2 dysfunction increases serum uric acid by decreased intestinal urate excretion.
Takada T; Ichida K; Matsuo H; Nakayama A; Murakami K; Yamanashi Y; Kasuga H; Shinomiya N; Suzuki H
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):275-81. PubMed ID: 24940679
[TBL] [Abstract][Full Text] [Related]
16. The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people.
Yamagishi K; Tanigawa T; Kitamura A; Köttgen A; Folsom AR; Iso H;
Rheumatology (Oxford); 2010 Aug; 49(8):1461-5. PubMed ID: 20421215
[TBL] [Abstract][Full Text] [Related]
17. The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update.
Eckenstaler R; Benndorf RA
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206432
[TBL] [Abstract][Full Text] [Related]
18. Urate Transporter ABCG2 Function and Asymptomatic Hyperuricemia: A Retrospective Cohort Study of CKD Progression.
Ohashi Y; Kuriyama S; Nakano T; Sekine M; Toyoda Y; Nakayama A; Takada T; Kawamura Y; Nakamura T; Matsuo H; Yokoo T; Ichida K
Am J Kidney Dis; 2023 Feb; 81(2):134-144.e1. PubMed ID: 35810827
[TBL] [Abstract][Full Text] [Related]
19. Clinical and genetic features of diuretic-associated gout: a case-control study.
Mitnala S; Phipps-Green A; Franklin C; Horne A; Stamp LK; Merriman TR; Dalbeth N
Rheumatology (Oxford); 2016 Jul; 55(7):1172-6. PubMed ID: 26989110
[TBL] [Abstract][Full Text] [Related]
20. The genetic basis of hyperuricaemia and gout.
Merriman TR; Dalbeth N
Joint Bone Spine; 2011 Jan; 78(1):35-40. PubMed ID: 20472486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]